Lymphocyte studies in rheumatoid arthritis. V. Suppressor cell function in peripheral blood. 1982

V Patel, and G S Panayi, and P Shepherd, and M Richter, and J Harkness, and T Gibson

Peripheral blood lymphocytes from 30 patients with rheumatoid arthritis and 14 controls were examined for suppressor activity by two different assays. These were the Concanavalin-A-induced and the short-lived suppressor cell assays. There was no difference in suppressor activity between patients and controls, the suppressor activity of HLA-DR3 positive patients was no less than that of non-DR3 patients. However, patients with nodules showed reduced suppression in the short-lived suppressor cell assay when compared with patients without nodules.

UI MeSH Term Description Entries
D007118 Immunoassay A technique using antibodies for identifying or quantifying a substance. Usually the substance being studied serves as antigen both in antibody production and in measurement of antibody by the test substance. Immunochromatographic Assay,Assay, Immunochromatographic,Assays, Immunochromatographic,Immunoassays,Immunochromatographic Assays
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003208 Concanavalin A A MANNOSE/GLUCOSE binding lectin isolated from the jack bean (Canavalia ensiformis). It is a potent mitogen used to stimulate cell proliferation in lymphocytes, primarily T-lymphocyte, cultures.
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000949 Histocompatibility Antigens Class II Large, transmembrane, non-covalently linked glycoproteins (alpha and beta). Both chains can be polymorphic although there is more structural variation in the beta chains. The class II antigens in humans are called HLA-D ANTIGENS and are coded by a gene on chromosome 6. In mice, two genes named IA and IE on chromosome 17 code for the H-2 antigens. The antigens are found on B-lymphocytes, macrophages, epidermal cells, and sperm and are thought to mediate the competence of and cellular cooperation in the immune response. The term IA antigens used to refer only to the proteins encoded by the IA genes in the mouse, but is now used as a generic term for any class II histocompatibility antigen. Antigens, Immune Response,Class II Antigens,Class II Histocompatibility Antigen,Class II Major Histocompatibility Antigen,Ia Antigens,Ia-Like Antigen,Ia-Like Antigens,Immune Response Antigens,Immune-Associated Antigens,Immune-Response-Associated Antigens,MHC Class II Molecule,MHC II Peptide,Class II Antigen,Class II Histocompatibility Antigens,Class II MHC Proteins,Class II Major Histocompatibility Antigens,Class II Major Histocompatibility Molecules,I-A Antigen,I-A-Antigen,IA Antigen,MHC Class II Molecules,MHC II Peptides,MHC-II Molecules,Antigen, Class II,Antigen, I-A,Antigen, IA,Antigen, Ia-Like,Antigens, Class II,Antigens, Ia,Antigens, Ia-Like,Antigens, Immune-Associated,Antigens, Immune-Response-Associated,I A Antigen,II Peptide, MHC,Ia Like Antigen,Ia Like Antigens,Immune Associated Antigens,Immune Response Associated Antigens,MHC II Molecules,Molecules, MHC-II,Peptide, MHC II,Peptides, MHC II
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis
D001327 Autoimmune Diseases Disorders that are characterized by the production of antibodies that react with host tissues or immune effector cells that are autoreactive to endogenous peptides. Autoimmune Disease,Disease, Autoimmune,Diseases, Autoimmune

Related Publications

V Patel, and G S Panayi, and P Shepherd, and M Richter, and J Harkness, and T Gibson
January 1981, Scandinavian journal of immunology,
V Patel, and G S Panayi, and P Shepherd, and M Richter, and J Harkness, and T Gibson
March 1982, The New England journal of medicine,
V Patel, and G S Panayi, and P Shepherd, and M Richter, and J Harkness, and T Gibson
January 1979, Agents and actions. Supplements,
V Patel, and G S Panayi, and P Shepherd, and M Richter, and J Harkness, and T Gibson
February 1990, Arthritis and rheumatism,
V Patel, and G S Panayi, and P Shepherd, and M Richter, and J Harkness, and T Gibson
October 1982, Journal of clinical & laboratory immunology,
V Patel, and G S Panayi, and P Shepherd, and M Richter, and J Harkness, and T Gibson
October 1978, Annals of the rheumatic diseases,
V Patel, and G S Panayi, and P Shepherd, and M Richter, and J Harkness, and T Gibson
November 1981, The New England journal of medicine,
V Patel, and G S Panayi, and P Shepherd, and M Richter, and J Harkness, and T Gibson
June 1978, Clinical and experimental immunology,
V Patel, and G S Panayi, and P Shepherd, and M Richter, and J Harkness, and T Gibson
June 1993, The Journal of experimental medicine,
V Patel, and G S Panayi, and P Shepherd, and M Richter, and J Harkness, and T Gibson
January 1989, Clinical and experimental rheumatology,
Copied contents to your clipboard!